Alembic Pharma gets USFDA nod to market conjunctivitis treatment drug

The approved product is therapeutically equivalent to the reference listed drug Optivar Ophthalmic Solution of Mylan Specialty L P.

from Latest News https://ift.tt/2YfsPvR
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share